Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

creatinine/diarrhea

リンクがクリップボードに保存されます
ページ 1 から 64 結果

Role of Montelukast in Modulation of Response to Sepsis in Preterm Infants

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Since inflammatory mediators play a crucial role in the pathophysiology of sepsis so anti-inflammatory treatment, Montelukast, could be a beneficial therapy. The investigators will conduct this pilot, open-labeled, randomized controlled intervention trial on 40 newborns admitted to NICU. The study

Northeast COVID-19 and Pregnancy Study Group

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
General Objective: To determine the frequency of COVID-19 in pregnant and postpartum women admitted with flu syndrome, to evaluate the clinical and laboratory predictors of COVID-19 progression and to identify the factors associated with adverse maternal and perinatal / neonatal outcomes in six

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Patients aged 18-80 years who confirmed with COVID-19 and classified as severe were enrolled in the study, and then separated randomly into two groups: a berberine group (B group) and a control group (C group). The diagnostic criteria for severe cases are in accordance with the Diagnosis and

Determinants of COVID-19 Pneumonia (MC-19)

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
As demonstrated by a study conducted by Ai et al., including 1014 suspect COVID-19 cases who underwent multiple RT-PCR testing and chest-CT, overall 88% of patients had positive CT scans while RT-PCR positivity was found only in 59% of all cases. Also, as reported by Yang et al, the total positive

COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Design: Retrospective cohort study that will review the data of patients seen in participating centers with a confirmed or probable diagnosis of COVID-19 between March and April 2020. Those patients who test positive for nasopharyngeal exudate for SARS-CoV-2 will be considered a confirmed case using

Prospective Randomized Clinical Trial on Oral and Intravenous Antibiotic Prophylaxis in Colorectal Surgery.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
This study is a Multicenter, Prospective, Randomized, Controlled Trial on preoperative oral antibiotics prophylaxis in colorectal surgery. INCLUSION & EXCLUSION CRITERIA: All consecutive patients undergoing elective colorectal resection should be included in the trial. Exclusion criteria: -

Efficacy and Safety of Favipiravir in Management of COVID-19

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Study Procedures: Screening phase: - Obtaining an informed consent - Written signed and dated informed consent will be obtained from each patient before being entered into the study. The investigator, or a person designated by the investigator, should fully inform the subject or, if the subject is

National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
This cross-sectional survey was initiated and conducted by the French Society of Geriatrics and Gerontology. A standardized questionnaire was emailed to 1600 geriatrician members of the French Society of Geriatrics and Gerontology throughout France between March 22, 2020 and April 5, 2020.

Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Patients admitted to Assiut University hospital, Al Rajhi liver hospital and other covid-19 Quarantine hospitals will be included. The characteristics of patients will be described such as demographic data; age, sex,history of contact to COVID-19 patients or traveling abroad and their clinical

Prognostic Factors Keeping Track for COVID-19 Pneumonia

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
It has been reported that nearly half of the patients who are hospitalized for Covid-19 pneumonia have on admission old age or comorbidities. In particular, hypertension was present in 30% of the cases, diabetes in 19%, coronary heart disease in 8% and chronic obstructive lung disease in 3% of the

A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
This study is a multi-center, randomized, open, blank-controlled, multi-stage clinical study. As there are no effective treatments, the project team will evaluate possible treatments (including but not limited to Pirfenidone) based on actual conditions. Ketone, Pirfenidone, lopinavir / ritonavir,

Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Study procedures 1. Written informed consent before study specific procedures are undertaken. The investigators will explain the contents of the trial especially the information about the possible side effects, other alternative treatment and the right to withdraw based on the participant own

Oral Dextrose Formula in Performance of Soccer Athlete

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Male academy soccer players, included in a trial, received two types of solutions (compound of 150 cc dextrose 10% + 20 mM sodium or single 150 cc dextrose 10%) interchangeably, separated within 120 minutes were completed in a counterbalanced, randomized, double-blind, crossover design. The study

Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Randomized, open-label, parallel-group, multicenter, phase III trial with two arms, one with acalabrutinib (Arm A) and the other with the standard of care for the management of early Binet stage A patients "clinical observation (watch & wait)" (Arm B) in patients with untreated early stage CLL and

Probiotics in Metformin Intolerant Patients With Type 2 Diabetes

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The optimal daily dose of metformin is thought to be 2000 mg, however patients with metformin intolerance cannot reach this target dose. Participate in this study are metformin intolerant. Metformin intolerant patients have been defined as those not able to be treated with the metformin daily dose
Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge